<DOC>
	<DOCNO>NCT01013194</DOCNO>
	<brief_summary>The herein study consist transplantation liver progenitor cell isolated human fetal liver tissue aim improve conventional liver therapy broaden therapeutical option liver transplantation .</brief_summary>
	<brief_title>Human Fetal Liver Cell Transplantation Chronic Liver Failure</brief_title>
	<detailed_description>One major clinical problem transplantation medicine discrepancy grow number liver chronic disease patient lack organ . Research development new liver failure treatment thus high clinical significance . Regenerative medicine result recently achieve field stem cell biology may provide remedy emerge problem . Our project aim develop new generation cell transplantation methodology interdisciplinary research project create collaboration ISMETT , Palermo University Pittsburgh ( UPMC-USA ) . Adult hepatocyte transplantation use several year already prove safe patient able , especially pediatric patient , improve liver function index delay need liver transplantation . Studies limit use already differentiate hepatocytes therefore unable proliferate develop suitable liver mass support decompensated liver . The hypothesis project , support vitro study study experimental animal model , base possibility generate ectopic liver system spleen experimental use hepatic cell progenitor obtain human fetal liver tissue . Human fetal liver cell transplantation perform spleen arterial injection . The final endpoint project develop innovative safe treatment patient end-stage chronic liver failure</detailed_description>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Liver Failure</mesh_term>
	<mesh_term>End Stage Liver Disease</mesh_term>
	<mesh_term>Liver Extracts</mesh_term>
	<criteria>Clinical diagnosis ( evidence chronic liver disease , presence ascites and/or esophageal varix upon superior digestive endoscopy and/or ultrasound evidence portal hypertension ) histological diagnosis liver cirrhosis etiology . Serious liver failure document score ≥ B8 base ChildPughTurcotte classification and/or MELD score ≥ 14 . Informed consent study sign patient . MELD score ≥ 25 Hepatocellular carcinoma ( HCC ) Portal vein thrombosis Serious cardiovascular respiratory disease , medical condition may threaten patient 's life subsequent three month Admission Intensive Care Unit ( ICU ) Hemodynamic instability ( MAP &lt; 55 mmHg ) Use vasoactive drug ( Epinephrine , Norepinephrine , Vasopressin , Dopamine , Terlipressine Type1 ( acute ) hepatorenal syndrome Levels serum creatinine &gt; 2 mg/dl and/or creatinine clearance &lt; 3040 ml/min Sepsis , active infection spontaneous bacterial peritonitis Active gastrointestinal bleeding recent gastrointestinal bleeding episode ( previous 4 week ) Active alcohol abuse Severe alcoholic hepatitis Pulmonary hypertension ( PAP &gt; 35 mmHg ) History neoplasia Pregnancy Non Sicilian residency HBV DNA positive HIV infection Drug addiction Age &lt; 18 year Transjugular intrahepatic portosystemic shunt ( TIPS ) place previous month Contraindications procedure ( e.g. , related splenic artery : aneurysm , kinking , thrombosis , splenicrenal shunt ; relate spleen : large angioma ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Liver cirrhosis</keyword>
	<keyword>Fetal stem cell</keyword>
	<keyword>Stem cell transplantation</keyword>
	<keyword>Liver transplant candidate</keyword>
</DOC>